These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2199349)

  • 1. Successful use of vancomycin hydrochloride in the treatment of lactulose resistant chronic hepatic encephalopathy.
    Tarao K; Ikeda T; Hayashi K; Sakurai A; Okada T; Ito T; Karube H; Nomoto T; Mizuno T; Shindo K
    Gut; 1990 Jun; 31(6):702-6. PubMed ID: 2199349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.
    Conn HO; Leevy CM; Vlahcevic ZR; Rodgers JB; Maddrey WC; Seeff L; Levy LL
    Gastroenterology; 1977 Apr; 72(4 Pt 1):573-83. PubMed ID: 14049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful use of vancomycin hydrochloride in the treatment of lactulose-resistant chronic hepatic encephalopathy.
    Tarao K; Ikeda T; Hayashi K; Sakurai A
    J Gastroenterol Hepatol; 1989; 4 Suppl 1():284-6. PubMed ID: 2519078
    [No Abstract]   [Full Text] [Related]  

  • 4. Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial.
    Atterbury CE; Maddrey WC; Conn HO
    Am J Dig Dis; 1978 May; 23(5):398-406. PubMed ID: 354373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactulose.
    Lanthier PL; Morgan MY
    Gut; 1985 Apr; 26(4):415-20. PubMed ID: 3979914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rectal administration of lactulose.
    Ratnaike RN; Hicks EP; Hislop IG
    Aust N Z J Med; 1975 Apr; 5(2):137-40. PubMed ID: 240347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperammoniemia and porta-caval encephalopathy in patients with cirrhosis. Personal results of lactulose treatment].
    Butti A; Bianco S; Bergonzi P; Cagossi M; Civello IM; Borzone A; Nanni G; Pigliucci GM
    Chir Patol Sper; 1975 Apr; 23(2):77-95. PubMed ID: 1140038
    [No Abstract]   [Full Text] [Related]  

  • 8. Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial.
    Elkington SG; Floch MH; Conn HO
    N Engl J Med; 1969 Aug; 281(8):408-12. PubMed ID: 4894464
    [No Abstract]   [Full Text] [Related]  

  • 9. Lactitol vs. lactulose in the treatment of chronic recurrent portal-systemic encephalopathy.
    Heredia D; Terés J; Orteu N; Rodés J
    J Hepatol; 1988 Aug; 7(1):106-10. PubMed ID: 3053887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactitol versus lactulose in the treatment of acute portal systemic encephalopathy (PSE). A controlled trial.
    Heredia D; Caballería J; Arroyo V; Ravelli G; Rodés J
    J Hepatol; 1987 Jun; 4(3):293-8. PubMed ID: 3598162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enterococcus lactic acid bacteria strain SF68 and lactulose in hepatic encephalopathy: a controlled study.
    Loguercio C; Del Vecchio Blanco C; Coltorti M
    J Int Med Res; 1987; 15(6):335-43. PubMed ID: 3125077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy for hepatic encephalopathy.
    Phongsamran PV; Kim JW; Cupo Abbott J; Rosenblatt A
    Drugs; 2010 Jun; 70(9):1131-48. PubMed ID: 20518580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose.
    Pirotte J; Guffens JM; Devos J
    Digestion; 1974; 10(6):435-44. PubMed ID: 4448315
    [No Abstract]   [Full Text] [Related]  

  • 14. Sodium benzoate in the treatment of acute hepatic encephalopathy: a double-blind randomized trial.
    Sushma S; Dasarathy S; Tandon RK; Jain S; Gupta S; Bhist MS
    Hepatology; 1992 Jul; 16(1):138-44. PubMed ID: 1618465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial.
    Morgan MY; Hawley KE
    Hepatology; 1987; 7(6):1278-84. PubMed ID: 3315932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactulose (cephulac) in portosystemic encephalopathy.
    Kosman ME
    JAMA; 1976 Nov; 236(21):2444-5. PubMed ID: 989871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides.
    Morgan MY
    Metab Brain Dis; 2016 Dec; 31(6):1361-1364. PubMed ID: 27638474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of chronic portal-systemic encephalopathy with lactulose. Report of six patients and review of the literature.
    Bircher J; Haemmerli UP; Scollo-Lavizzari G; Hoffmann K
    Am J Med; 1971 Aug; 51(2):148-59. PubMed ID: 5095524
    [No Abstract]   [Full Text] [Related]  

  • 19. Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over study.
    Morgan MY; Hawley KE; Stambuk D
    J Hepatol; 1987 Apr; 4(2):236-44. PubMed ID: 3295020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactulose: a drug in search of a modus operandi.
    Conn HO
    Gastroenterology; 1978 Mar; 74(3):624-6. PubMed ID: 24572
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.